Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1

Background: The adoption of combined chemotherapy (CT) and immunotherapy (IO) has advanced neoadjuvant therapy (NA) for non-small cell lung cancer (NSCLC), but data on functional impacts are limited. This multicenter retrospective study evaluates respiratory function in NSCLC patients undergoing NA....

Full description

Saved in:
Bibliographic Details
Main Authors: M Sereno, A Collazo-Lorduy, Y Garitaonaindia, D Gómez de Antonio, J Baena Espinar, C Aguado de la Rosa, P Cruz Castellanos, S Falagán Martínez, LE Chara Valverde, R López-Castro, A López-Martin, J Rubio-Pérez, A Gómez Rueda, C Traseira Puchol, X Mielgo Rubio, B Losada Vila, J Rogado, E Bernal Hertfelder, L Gutiérrez Sainz, JL Campo-Cañaveral, I Romano, I. Thuissard, G Rubio Romero, E Casado Sáenz
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Neoadjuvant
Operability
DLCO
Chemo-inmunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294225000474
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468294225000474

Similar Items